Detalhe da pesquisa
1.
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
Immunity;
53(1): 98-105.e5, 2020 07 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32561270
2.
Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen-specific glycopolymer.
J Neurochem;
154(5): 486-501, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32270492
3.
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
J Immunol;
201(1): 98-112, 2018 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29769270
4.
Interaction of biomedical nanoparticles with the pulmonary immune system.
J Nanobiotechnology;
15(1): 6, 2017 Jan 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28069025
5.
Virosome-bound antigen enhances DC-dependent specific CD4+ T cell stimulation, inducing a Th1 and Treg profile in vitro.
Nanomedicine;
13(5): 1725-1737, 2017 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28214610
6.
Pulmonary delivery of cationic gold nanoparticles boost antigen-specific CD4+ T Cell Proliferation.
Nanomedicine;
12(7): 1815-1826, 2016 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27013126
7.
Size-dependent uptake of particles by pulmonary antigen-presenting cell populations and trafficking to regional lymph nodes.
Am J Respir Cell Mol Biol;
49(1): 67-77, 2013 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23492193
8.
Formulated Phospholipids as Non-Canonical TLR4 Agonists.
Pharmaceutics;
14(12)2022 Nov 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36559051
9.
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.
Cell Rep;
35(5): 109084, 2021 05 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33951425
10.
Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model.
Front Pharmacol;
12: 799034, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35126135
11.
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
Science;
2021 Mar 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33766944
12.
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
medRxiv;
2021 Mar 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33758873
13.
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.
Cell Rep;
36(2): 109353, 2021 07 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34237283
14.
Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments.
NPJ Vaccines;
5: 83, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32983577
15.
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation.
Nat Commun;
11(1): 5413, 2020 10 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33110068
16.
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual.
bioRxiv;
2020 May 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32511342
17.
The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine.
NPJ Vaccines;
4: 19, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31149350
18.
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology.
NPJ Vaccines;
4: 1, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30622742
19.
Current in vitro approaches to assess nanoparticle interactions with lung cells.
Nanomedicine (Lond);
11(18): 2457-69, 2016 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27529369
20.
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.
Cell Rep;
36(3): 109454, 2021 Jul 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34289363